Capital Financial Services’s Gilead Sciences GILD Stock Holding History

Capital Financial Services’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	$901K	Sell	10,490 -250	-2%	-$19.8K	1.24%	30
2022 Q3	$663K	Sell	10,740 -450	-4%	-$28.4K	0.98%	38
2022 Q2	$692K	Sell	11,190 -700	-6%	-$43.3K	0.98%	38
2022 Q1	$707K	Sell	11,890 -250	-2%	-$16K	0.83%	40
2021 Q4	$881K	Sell	12,140 -3,175	-21%	-$219K	0.96%	35
2021 Q3	$1.07M	Sell	15,315 -50	-0.3%	-$3.51K	1.31%	29
2021 Q2	$1.06M	Sell	15,365 -200	-1%	-$13.4K	1.34%	27
2021 Q1	$1.01M	Buy	15,565 +125	+0.8%	+$8.06K	1.34%	28
2020 Q4	$900K	Buy	+15,440	New	+$932K	1.25%	28

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Financial Services's GILD Position: Q4 2022 in Review

Capital Financial Services reduced its Gilead Sciences (GILD) stake by 2.3% in Q4 2022, selling an estimated $19.8K and leaving 10,490 shares worth $901K. The position accounts for 1.24% of the portfolio, ranked #30.

Capital Financial Services first reported a position in GILD in Q4 2020 and has held it in 9 quarters since. The position peaked at $1.07M in Q3 2021. 1,767 funds tracked by Wall St. Rank hold GILD as of Q4 2022.

Capital Financial Services held 10,490 shares of Gilead Sciences worth $901K as of Q4 2022.
Capital Financial Services sold 250 Gilead Sciences shares in Q4 2022, an estimated $19.8K.
Gilead Sciences made up 1.24% of Capital Financial Services's portfolio in Q4 2022, its #30 holding.
Capital Financial Services first reported a position in Gilead Sciences in Q4 2020 and has held it in 9 quarters since.
Capital Financial Services's Gilead Sciences position peaked at $1.07M in Q3 2021.
1,767 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2022.

Based on Capital Financial Services's 13F filing for Q4 2022, filed 23 Jan 2023.